Eucalyptus Secures Funding to Revolutionize Global Healthcare with Innovative Telehealth Services

Eucalyptus has etched its name in the ever-evolving landscape of healthcare technology with its digital health solutions that are bridging the gap between patients and healthcare providers. The healthcare technology company, founded in 2019 and based out of Australia, recently secured funding of $137.6 million, accomplishing a significant milestone in its mission to revolutionize how healthcare is delivered. 

With a strong focus on telehealth consultations, delivery of pharmaceutical products, and ongoing patient care, Eucalyptus is the umbrella brand for a suite of digital health services that cater to a diverse population. It functions as an interconnected network of healthcare provisions, each addressing a specific health concern. 

The company’s portfolio includes Pilot - focusing on men’s health and weight loss, Juniper - specializing in women’s weight loss, Kin - targeting fertility support, and Software - endorsing prescription skincare. These services operate their own telehealth clinics, but the company also has another brand called Normal, promoting sexual wellness. 

Eucalyptus’ portfolio

(Image source: Greenhouse)

The Global Expansion of Telehealth Clinics

With a team of almost 500 professionals, Eucalyptus has managed to facilitate more than 800,000 online consultations and serve nearly 600,000 patients worldwide. These patients interact with registered clinicians who develop personalized treatment plans for them and transmit the e-scripts to pharmacies that have partnered with the company. While an integrated team of caregivers provides ongoing support to users, the virtual community encourages them to build connections and share their experiences or insights with others. 

Medicare, Australia’s national public health system, has saved up to $30 million with Eucalyptus’s initiatives. This achievement is credited to the company’s personalized treatments and programs that have succeeded in not only identifying various health conditions but also managing them from afar. For instance, Juniper helped detect 100 undiagnosed Type 2 diabetic patients and an additional 1,000 pre-diabetic patients. This proved the platform’s potential to address critical health concerns. 

Having launched Juniper in the UK and Germany, one of Eucalyptus’ key focuses is to expand globally. With obesity rates skyrocketing, the company aims to reduce the risk of diseases like Type 2 diabetes by guiding individuals to manage their weight effectively. Japan has already been established as one of the world's most prospective healthcare markets. Eucalyptus’ strategy to collaborate with local advisors, engage with clinics through cold-calling, and use Austrade’s support to forge new connections has helped the company pave the way for new partnerships.

Eucalyptus founders Benny Kleist, Charlie Gearside, Tim Doyle, and Alexey Mitlo

(Image source: Blackbird)

Strategic Partnerships for Future Ventures

Eucalyptus is actively partnering with clinics to provide consultations and prescribe medicines to users. The company recognizes the importance of approaching healthcare holistically and is now incorporating dieticians and nutritionists to assist patients with sustainable lifestyle changes. The recent funding of $137.6 million will undoubtedly strengthen Eucalyptus' position in the market to further its mission and expand its offerings.

Looking ahead, Eucalyptus has ambitious plans for market expansion. In addition to Japan, India and Southeast Asia have also been identified as prime markets for the company's next phase of growth. After Jupiter, Eucalyptus aims to launch its other brands in the UK, and Germany. Its desire to make comprehensive healthcare through digital platforms more accessible is perfectly in line with the world’s growing demand for telehealth services.

Wrapping Up

Eucalyptus is spearheading several innovations in healthcare by making the most of technology to provide tailored solutions that are both effective and affordable. With the recent injection of funds and an impressive portfolio of digital brands, the company is set to leave a lasting impact in the world of telehealth. As Eucalyptus continues to expand its reach and services, it showcases the transformative power of telehealth in improving patient care, adopting preventive measures, and optimizing delivery systems.